Financial results - EDALMED LINE SRL

Financial Summary - Edalmed Line Srl
Unique identification code: 33890223
Registration number: J16/1912/2014
Nace: 4646
Sales - Ron
290.845
Net Profit - Ron
14.879
Employee
2
The most important financial indicators for the company Edalmed Line Srl - Unique Identification Number 33890223: sales in 2023 was 290.845 euro, registering a net profit of 14.879 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Edalmed Line Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 0 97.432 132.568 94.015 119.077 123.361 350.974 244.294 259.323 290.845
Total Income - EUR 0 97.432 132.572 94.016 119.078 123.361 351.860 244.355 259.335 291.104
Total Expenses - EUR 46 90.612 116.049 85.492 106.155 118.638 311.446 224.191 237.004 273.812
Gross Profit/Loss - EUR -46 6.820 16.522 8.524 12.923 4.723 40.414 20.163 22.331 17.292
Net Profit/Loss - EUR -46 5.268 13.955 6.783 11.732 3.489 37.456 18.183 20.128 14.879
Employees 0 1 2 1 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 12.5%, from 259.323 euro in the year 2022, to 290.845 euro in 2023. The Net Profit decreased by -5.189 euro, from 20.128 euro in 2022, to 14.879 in the last year.

Check the financial reports for the company - Edalmed Line Srl

Rating financiar

Financial Rating -
Edalmed Line Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Edalmed Line Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Edalmed Line Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Edalmed Line Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Edalmed Line Srl - CUI 33890223

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 140 15.993 11.962 7.938 4.052 611 16.632 11.751 7.320 2.896
Current Assets 44 51.410 45.426 24.016 30.520 29.865 61.238 46.296 92.703 82.258
Inventories 0 1.791 3.545 1.761 411 4.673 6.145 6.360 6.811 7.047
Receivables 6 30.655 34.085 10.002 17.001 15.925 43.588 28.538 77.798 58.962
Cash 37 18.964 7.796 12.253 13.109 9.267 11.504 11.398 8.094 16.248
Shareholders Funds -1 5.281 14.046 11.627 11.798 7.537 37.516 22.311 20.181 14.975
Social Capital 0 45 45 44 43 42 41 40 41 40
Debts 185 62.490 43.546 20.500 22.957 23.398 40.478 35.735 79.842 70.316
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 82.258 euro in 2023 which includes Inventories of 7.047 euro, Receivables of 58.962 euro and cash availability of 16.248 euro.
The company's Equity was valued at 14.975 euro, while total Liabilities amounted to 70.316 euro. Equity decreased by -5.145 euro, from 20.181 euro in 2022, to 14.975 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Edalmed Line Srl

Comments - Edalmed Line Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.